News

Knee Perturbator Studies How Legs Recover from Stumbles to Improve Prostheses

by  • 

Lower limb prostheses are becoming competitive with real legs in terms of strength, running speed, and other characteristics. One important factor these devices are still missing compared to natural legs is the brain’s assistance when recovering from a stumble. Now researchers at ETH Zurich and National Centre of Competence in Research (NCCR) Robotics in Switzerland are studying […]

The post Knee Perturbator Studies How Legs Recover from Stumbles to Improve Prostheses appeared first on Medgadget.

Read more →

News

Stentrodes for Recording Electrical Activity Within the Brain

by  • 

Being able to accurately record brain activity over long periods of time holds promise for paralyzed people to control prosthetic devices or even their own arms and legs again. That’s can be thought of as only a start of course, as the brain is central to many diseases and conditions, as well as being a […]

The post Stentrodes for Recording Electrical Activity Within the Brain appeared first on Medgadget.

Read more →

Business, News

Aerpio Therapeutics Announces Presentation of Positive Results of AKB-9778 in Patients with Diabetic Retinopathy from TIME-2 Phase 2a Study

by  • 

CINCINNATI–(BUSINESS WIRE)–Aerpio Therapeutics, Inc., a biopharmaceutical company focused on advancing first-in-class treatments for the eye, today announced promising results in diabetic retinopathy from the company’s phase 2a study (“TIME-2”) of its lead candidate, AKB-9778, a first-in-class Tie2 activator. AKB-9778, dosed at 15 mg BID subcutaneously, alone and in combination with Lucentis® (ranibizumab injection dosed at 0.3 mg intravitreally), improved underlying retinopathy according to


Read more →